BREAKING

Global markets surge as central banks signal pause on interest rate hikes AI breakthrough: New model achieves human-level reasoning across all domains World leaders convene emergency climate summit amid record-breaking temperatures

LIVE MARKETS

US📈 S&P 500$5,738.17▲ 0.41% METAL🥇 GOLD$2,658.40/oz▲ 0.52% ENERGY🛢️ BRENT$71.89/bbl▲ 0.68% CRYPTO₿ BTC$65,840.00▲ 1.85% IN🇮🇳 NIFTY 50₹26,178.95▲ 0.30% METAL🥈 SILVER$31.62/oz▲ 1.18% US💻 NASDAQ$18,179.59▲ 0.60% ENERGY🛢️ WTI CRUDE$68.18/bbl▲ 0.75% CRYPTOΞ ETH$2,664.20▲ 2.10% IN🇮🇳 SENSEX₹85,571.85▲ 0.28% US🏛️ DOW$42,313.00▲ 0.33% CRYPTO◎ SOL$156.40▲ 4.30% UK🇬🇧 FTSE 100£8,320.72▲ 0.43% CRYPTO⬡ BNB$598.20▲ 0.85% US📈 S&P 500$5,738.17▲ 0.41% METAL🥇 GOLD$2,658.40/oz▲ 0.52% ENERGY🛢️ BRENT$71.89/bbl▲ 0.68% CRYPTO₿ BTC$65,840.00▲ 1.85% IN🇮🇳 NIFTY 50₹26,178.95▲ 0.30% METAL🥈 SILVER$31.62/oz▲ 1.18% US💻 NASDAQ$18,179.59▲ 0.60% ENERGY🛢️ WTI CRUDE$68.18/bbl▲ 0.75% CRYPTOΞ ETH$2,664.20▲ 2.10% IN🇮🇳 SENSEX₹85,571.85▲ 0.28% US🏛️ DOW$42,313.00▲ 0.33% CRYPTO◎ SOL$156.40▲ 4.30% UK🇬🇧 FTSE 100£8,320.72▲ 0.43% CRYPTO⬡ BNB$598.20▲ 0.85%

Markets

World • 1 min read • Sep 28, 2026

Mirum Pharma's Atebrioz Gets USFDA Nod for Rare Bone Disorder FOP

Bengaluru: The US Food and Drug Administration has approved Mirum Pharmaceuticals' drug to treat a rare bone disorder, the regulator said on Friday.The drug, zilurgisertib, branded as Atebrioz, is a...

Staff Reporter

0 views

Mirum Pharma's Atebrioz Gets USFDA Nod for Rare Bone Disorder FOP

Mirum Pharma's Atebrioz Gets USFDA Nod for Rare Bone Disorder FOP

Comments (0)

Leave a Comment

Related Articles

Comments (0)

Leave a Comment